Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic Acid in Burn Debridement
NCT05855590Phase 3Unknown
- Sponsor
- Instituto Mexicano del Seguro Social
- Start
- Jan 2022
- Primary completion
- Jan 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tranexamic acid in burn injury, sponsored by Instituto Mexicano del Seguro Social. Status: unknown.
02
Drugs
tranexamic acid
03
Conditions
burn injury
Beyond the preview
Go deeper on NCT05855590.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05855590.